Ben Katovsky said: “Today we are setting out a new identity for a new company. Recognition encapsulates the cultural ...

If you suffered losses exceeding $100,000 in Merck between February 3, 2022 and February 3, 2025 and would like to discuss ...

Merck & Co. Inc. closed 29.59% below its 52-week high of $134.63, which the company reached on June 25th.

NEW YORK, NY / ACCESS Newswire / March 17, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn ...

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Jimmy Investor. In this article, we will summarize ...

Investors with a lot of money to spend have taken a bullish stance on Merck & Co MRK. And retail traders should know. We noticed this today when the positions showed up on publicly available ...

We recently published a list of 10 Most Undervalued S&P 500 Stocks to Buy Now. In this article, we are going to take a look at where Merck & Co Inc. (NYSE:MRK) stands against other undervalued S&P 500 ...

With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...

Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish ...

In what’s shaping up to be a red-letter week for Gardasil, Merck & Co. has simultaneously opened a massive new manufacturing facility for the human papillomavirus (HPV) shot in the U.S. and put ...

Merck (MRK) announced results from the Phase 3 KEYNOTE-966 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination ...

Merck (MRK), known as MSD outside of the United States and Canada, today provided an update on the open-label arm of the... By Davit Kirakosyan Wells Fargo upgraded Amgen (NASDAQ:AMGN) and Eli ...